Preprint
Article

Target Identification in Breast Cancer through Network Pharmacology

Altmetrics

Downloads

154

Views

46

Comments

0

Submitted:

21 May 2024

Posted:

24 May 2024

You are already at the latest version

Alerts
Abstract
In this study, we utilized the UniProt database to extract breast cancer genes Total 2658 genes in Homo sapiens are obtain. Then 166 genes are taken and after delating duplicates 158 genes were remains. These genes were then analyzed for their biological pathways using Gene Ontology enrichment analysis through the Genecodis platform, resulting in the identification of 12 unique genes involved in disease pathways. Protein-protein interaction (PPI) network analysis was conducted using the STRING database and Cytoscape software, identifying ANLN,TREM1,LZTFL1,OXSM,PLA2G3,TAS2R13,ABCB10,ECT2,TRPC,BCAS3,PLA2G3,ZDHHC7 and ERBB2 as potential gene targets for breast cancer.
Keywords: 
Subject: Biology and Life Sciences  -   Life Sciences

Introduction

Breast cancer: breast cancer is a type of cancer that starts in the breast cells and grows out of control. It's more common in women because they are exposed to estrogen throughout their lives. It's a leading cause of cancer death in women, making up about 20-25% of all cancers in women. One in eight women will develop breast cancer during their lives. Breast cancer is the most frequent type of cancer and the second leading cause of mortality for women after lung cancer. Any breast tissue, cell, or gland has the potential to become cancerous. It can start in the ducts that produce milk or in the glandular tissues known as lobules, which produce milk. If cancer cells are not found at an early stage, there is a potential that they will damage other areas of the body and spread. Breast tumours can either be benign or malignant; benign lesions are non-cancerous cell abnormalities that cannot develop into breast cancer, whereas malignant lesions are cancerous lesions.

Network Pharmacology

In 2007, Hopkins et al. first proposed the concept “network pharmacology”. This method analyzes the intervention of drugs and potential treated targets of diseases based on system biology. Network pharmacology highlights a paradigm shift from the current “one target, one drug” strategy to a novel version of the “network target, multi-component” strategy Recently, a new technique known as polypharmacology has emerged which is able to address the limitations with current drug discovery challenges. Poly-pharmacology, also known as network pharmacology, attempts to understand drug action and interactions with multiple targets (Hopkins, 2007). It uses computational power and computer-based virtual high-throughput screening for docking studies to improve the efficiency of discovery process.

Target Identification

Target identification is the process of identifying potential targets for drug development. This process typically involves the use of computational and experimental methods to identify proteins, enzymes, receptors, or other biological molecules that are involved in the pathways of interest, and that could be targeted by small molecule compounds in order to treat a specific disease or condition. By identifying potential targets, researchers can develop and test small molecule compounds that are designed to interact with these targets, in order to modulate their activity and exert a therapeutic effect.

Gene Ontology

Gene Ontology is one of the main resources of biological information since it provides a specific definition of protein functions.Gene Ontology is a powerful tool in bioinformatics that helps in the standardized representation of genes and their functions across different species.

String

Protein networks have become a popular tool for analyzing and visualizing the oftenlong lists of proteins or genes obtained from proteomics and other high-throughput technologies. One of the most popular sources of such networks is the STRING database, which provides protein networks for more than 2000 organisms, including both physical interactions from experimental data and functional associations from curated pathways, automatic text mining, and prediction methods.

Cytoscape

cytoscape utilizes a highly reliable gene functional interaction network combined with human curated pathways derived from Reactome and other pathway databases. Biologists can use this app to uncover network and pathway patterns related to their studies, search for gene signatures from gene expression data sets, reveal pathways significantly enriched by genes in a list, and integrate multiple genomic data types into a pathway context using probabilistic graphical models.

Materials and Methods

Text Mining

The Uniprot database(https://www.uniprot.org/) was utilized to obtain genes involved in breast cancer. In which from a total of 2658 genes in homo-sapiens 158 genes are extracted and dublicate were delated. These genes were analyzed for their biological pathways and involvement in disease pathology.

GO Enrichment Analysis

Gene Ontology is a powerful tool in bioinformatics that helps in the standardized representation of genes and their functions across different species that used in analysis of cellular componants and molecular pathway .The Genecodis(https://genecodis.genyo.es/) platform was utilized in the procedure. Information of 166 genes were acquired. From these pathways 10 unique genes were sorted out as per their involvement in disease pathways and those genes were further utilized for network analysis.

PPI Network Analysis

The STRINGS database (https://string-db.org/)is used to predict protein-protein interaction networks. The Cytoscape software is utilized to visualize and analyze PPI networks in which functional enrichment data for proteins in the network is obtained and also analyzed for PPI network parameters such as degree, betweenness and compartment/tissue score. By network analysis data different potential protein targets are predicted. These protein targets are further utilized for virtual screening by molecular docking.

Lead Identification

Lead identification is a key step in drug discovery where potential compounds with therapeutic effects are identified for further development.We utilized PubChem to explore the chemical constituents relevant to our study. We identified a total of 15 chemical constituents of green Tea, each of which plays a crucial role in our investigation. By leveraging PubChem's extensive database, we were able to comprehensively analyze the properties and characteristics of these constituents, contributing to a more thorough understanding of their potential effects and mechanisms of action within our research context.

Molecular Docking

Molecular docking is a computational technique used in the field of bioinformatics and drug discovery to predict the preferred orientation of one molecule when bound to another molecule to form a stable complex. This method helps in understanding the interactions between small molecules and proteins, which is crucial for designing new drugs or optimizing existing ones. By simulating the docking process, researchers can predict the binding affinity and mode of interaction between a ligand and receptor, aiding in the identification of potential drug candidates.
We use PDB software to download the gene structures necessary for our study.and,we utilized Pyrex software for molecular docking, a crucial step in our computational analysis. By leveraging these tools, we were able to obtain the structural data needed for docking simulations and predict the binding interactions between our ligands and receptors accurately. This approach enabled us to gain valuable insights into the molecular mechanisms underlying our research and facilitated the identification of potential drug candidates.

Results

UNIPROT KB: There are 158 genes are taken out of 2658 genes of breast cancer.

Go Enrichment Analysis

Go enrichment analysis was performed using Genecodis web platform. In the process top 10 pathways are selected which are associated with breast cancer. Significantly enriched genes are selectedTREM1,TRPC4,ERBB2,ANLN,ZDHHC7,LZTFL1,OXSM,PLA2G3,ECT2,TAS2R1 3,ABCB10,BCAS3,ERBB2.

PPI Network Analysis

The STRING database was used to develop the PPI network. The PPI network was visualized and analyzed using the Cytoscape app. Betweenness and Degree of centrality parameters from the Centiscape plugin were used to analyze the network. ANLN,TREM1,LZTFL1,OXSM,PLA2G3,TAS2R13,ABCB10,ECT2,TRPC,BCAS3,PLA2G3,ZDHHC7,ERBB2 this are the potential gene based on string analysis

Degree and betweenness Analysis

Result of target identification with degree and betweenness: Here we have identified the targets and candidate genes (Figure 5). We loaded data into Cytoscape in the “.tsv" format from the STRING EXPORT channel. Then, to evaluate each node's topological characteristics and identify the important nodes, we employed CentiScaPe, a software that computes a greater number of network characteristics. The total number of edges occurring to the node is represented by the node degree.

Molecular Docking

The PubMed database use for obtain chemical constituent of green tea, in that we taken 15 chemical constituent (Table 3). And download their structure from PubChem.
Targeted protein download from PDB data base,in that 5 protein structure download out of 10 protein. Then use Pyrex for molecular docking of protein and lead ,in that 3 protein show binding with 15 leads (Table 4).
Table 1. genes of breast cancer obtain from text mining.
Table 1. genes of breast cancer obtain from text mining.

Entry

Gene name

Q9H2R5

KLK15

Q9H2X6

HIPK2

Q9H2X9

SLC12A5 KCC2 KIAA1176

Q9H3D4

TP63 KET P63 P73H P73L TP73L

Q9H3H5

DPAGT1 DPAGT2

Q9H3M9

ATXN3L ATX3L MJDL

Q9H3R5

CENPH ICEN35

Q9H3T3

SEMA6B SEMAN SEMAZ UNQ1907/PRO4353

Q9H3V2

MS4A5 CD20L2 TETM4

Q9H3Y6

SRMS C20orf148

Q9H467

CUEDC2 C10orf66 HOYS6

Q9H4A3

WNK1 HSN2 KDP KIAA0344 PRKWNK1

Q9H4B4

PLK3 CNK FNK PRK

Q9H4D0

CLSTN2 CS2

Q9H4H8

FAM83D C20orf129

Q9H4L2

BRCA2

Q9H4L3

BRCA2

Q9H4T2

ZSCAN16 ZNF392 ZNF435

Q9H4X1

RGCC C13orf15 RGC32

Q9H582

ZNF644 KIAA1221 ZEP2

Q9H596

DUSP21 LMWDSP21

Q9H5I1

SUV39H2 KMT1B

Q9H5J0

ZBTB3

Q9H5V8

CDCP1 TRASK UNQ2486/PRO5773

Q9H6B1

ZNF385D ZNF659

Q9H6R7

WDCP C2orf44 PP384

Q9H6U6

BCAS3

Q9H7D7

WDR26 CDW2 MIP2 PRO0852

Q9H7L9

SUDS3 SAP45 SDS3

Q9H7N4

SCAF1 SFRS19 SRA1

Q9H7R0

ZNF442

Q9H7S9

ZNF703 ZEPPO1 ZPO1

Q9H813

PACC1 C1orf75 TMEM206

Q9H8L6

MMRN2 EMILIN3

Q9H8V3

ECT2

Q9H8Y1

VRTN C14orf115

Q9H910

JPT2 C16orf34 HN1L L11

Q9H9B1

EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D

Q9HAU4

SMURF2

Q9HAU8

RNPEPL1

Q9HAW4

CLSPN

Q9HAX1

DSC3

Q9HB09

BCL2L12 BPR

Q9HB58

SP110

Q9HBL0

TNS1 TNS

Q9HBT6

CDH20 CDH7L3

Q9HBW1

LRRC4 BAG NAG14 UNQ554/PRO1111

Q9HBX8

LGR6 UNQ6427/PRO21331 VTS20631

Q9HC10

OTOF FER1L2

Q9HC57

WFDC1 PS20

Q9HC96

CAPN10 KIAA1845

Q9HCE0

EPG5 KIAA1632

Q9HCE3

ZNF532 KIAA1629

Q9HCE6

ARHGEF10L GRINCHGEF KIAA1626

Q9HCH5

SYTL2 KIAA1597 SGA72M SLP2 SLP2A

Q9HCI5

MAGEE1 HCA1 KIAA1587

Q9HCS4

TCF7L1 TCF3

Q9HCU0

CD248 CD164L1 TEM1

Q9HCU9

BRMS1

Q9HD15

SRA1 PP7684


Q9HD64
XAGE1A GAGED2 XAGE1; XAGE1B XAGE1C XAGE1D XAGE1E

Q9HDB8

ERVK-5 ERVK5

Q9NP09

ERBB2

Q9NP58

ABCB6 MTABC3 PRP UMAT

Q9NP60

IL1RAPL2 IL1R9

Q9NP61

ARFGAP3 ARFGAP1

Q9NP99

TREM1

Q9NPC2

KCNK9 TASK3

Q9NPD5

SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8

Q9NPD8

UBE2T HSPC150 PIG50

Q9NPG8

ZDHHC4 ZNF374 DC1 UNQ5787/PRO19576

Q9NPY3

CD93 C1QR1 MXRA4

Q9NQ31

AKIP1 BCA3 C11orf17

Q9NQ48

LZTFL1

Q9NQ66

PLCB1 KIAA0581

Q9NQ88

TIGAR C12orf5

Q9NQB0

TCF7L2 TCF4

Q9NQC3

RTN4 KIAA0886 NOGO My043 SP1507

Q9NQG5

RPRD1B C20orf77 CREPT

Q9NQR3

BRCA1

Q9NQU5

PAK6 PAK5

Q9NQW6

ANLN

Q9NQX1

PRDM5 PFM2

Q9NR12

PDLIM7 ENIGMA

Q9NR30

DDX21

Q9NR80

ARHGEF4 KIAA1112

Q9NR82

KCNQ5

Q9NR96

TLR9 UNQ5798/PRO19605

Q9NRA2

SLC17A5

Q9NRC1

ST7 FAM4A1 HELG RAY1

Q9NRD0

FBXO8 FBS FBX8 DC10 UNQ1877/PRO4320

Q9NRH2

SNRK KIAA0096 SNFRK

Q9NRJ1

C8orf17

Q9NRK6

ABCB10

Q9NRM2

ZNF277 NRIF4 ZNF277P

Q9NRN9

METTL5 DC3 HSPC133

Q9NRP0

OSTC DC2 HDCMD45P HSPC307

Q9NRP7

STK36 KIAA1278

Q9NRY4

ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP

Q9NS23

RASSF1 RDA32

Q9NS39

ADARB2 ADAR3 RED2

Q9NS71

GKN1 AMP18 CA11 UNQ489/PRO1005

Q9NS87

KIF15 KLP2 KNSL7

Q9NSC7

ST6GALNAC1 SIAT7A UNQ543/PRO848

Q9NTF0

DKFZp727E011

Q9NTG1

PKDREJ

Q9NTK1

DEPP1 C10orf10 DEPP FIG

Q9NTK5

OLA1 GTPBP9 PRO2455 PTD004

Q9NTM9

CUTC CGI-32

Q9NTW7

ZFP64 ZNF338

Q9NTX7

RNF146

Q9NTX9

FAM217B C20orf177

Q9NU02

ANKEF1 ANKRD5

Q9NUM3

SLC39A9 ZIP9 UNQ714/PRO1377

Q9NUQ7

UFSP2 C4orf20

Q9NUT2

ABCB8 MABC1 MITOSUR

Q9NV12

TMEM140

Q9NV23

OLAH THEDC1

Q9NV64

TMEM39A SUSR2

Q9NVA1

UQCC1 BZFB C20orf44 UQCC

Q9NVD3

SETD4 C21orf18 C21orf27

Q9NVE7

PANK4

Q9NVM9

INTS13 ASUN C12orf11 GCT1

Q9NVP1

DDX18 cPERP-D

Q9NVW2

RLIM RNF12

Q9NVX2

NLE1 HUSSY-07

Q9NW75

GPATCH2 GPATC2

Q9NWB6

ARGLU1

Q9NWK9

ZNHIT6 BCD1 C1orf181

Q9NWM0

SMOX C20orf16 SMO UNQ3039/PRO9854

Q9NWU1

OXSM

Q9NX61

TMEM161A UNQ582/PRO1152

Q9NXF8

ZDHHC7

Q9NXL2

ARHGEF38

Q9NY72

SCN3B KIAA1158

Q9NY74

ETAA1 ETAA16

Q9NYC9

DNAH9 DNAH17L DNEL1 KIAA0357

Q9NYF0

DACT1 DPR1 HNG3

Q9NYV9

TAS2R13

Q9NZ20

PLA2G3

Q9NZ52

GGA3 KIAA0154

Q9NZC7

WWOX FOR SDR41C1 WOX1

Q9NZC9

SMARCAL1 HARP

Q9NZJ4

SACS KIAA0730

Q9NZJ5

EIF2AK3 PEK PERK

Q9NZL6

RGL1 KIAA0959 RGL

Q9NZP6

NPAP1 C15orf2

Q9P032

NDUFAF4 C6orf66 HRPAP20 HSPC125 My013

Q9P0G3

KLK14 KLKL6

Q9P253

VPS18 KIAA1475

Q9P260

RELCH KIAA1468

Q9P283

SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001

Q9P287

BCCIP TOK1

Q9P2J8

ZNF624 KIAA1349

Q9P2U8

SLC17A6 DNPI VGLUT2

Q9T3Q5

ND2 NADH2

Q9UBB6

NCDN KIAA0607

Q9UBF1

MAGEC2 HCA587 MAGEE1

Q9UBF9

MYOT TTID

Q9UBK9

UXT HSPC024

Q9UBN4

TRPC4

Q9UBN7

HDAC6 KIAA0901 JM21

Q9UBP0

SPAST ADPSP FSP2 KIAA1083 SPG4

Q9UBS9

SUCO C1orf9 CH1 OPT SLP1
Figure 1. GO enrichment analysis chart bar length signifies -log10(pval Ad)and red colour intensity signifies number of input genes involved in pathway.
Figure 1. GO enrichment analysis chart bar length signifies -log10(pval Ad)and red colour intensity signifies number of input genes involved in pathway.
Preprints 107087 g001
Figure 2. KEGG enrichment analysis chart bar length signifies -log10(pvalAdj) and red colour intensity signifies number of input genes involved in pathway.
Figure 2. KEGG enrichment analysis chart bar length signifies -log10(pvalAdj) and red colour intensity signifies number of input genes involved in pathway.
Preprints 107087 g002
Figure 3. Protein protein interaction in string database.network nodes represent proteins, different coloured edges represent protein-protein interaction.
Figure 3. Protein protein interaction in string database.network nodes represent proteins, different coloured edges represent protein-protein interaction.
Preprints 107087 g003
Figure 4. The protein-protein interaction network of genes and identification of candidate genes, produced using Cytoscape.
Figure 4. The protein-protein interaction network of genes and identification of candidate genes, produced using Cytoscape.
Preprints 107087 g004
Figure 5. The degree and betweenness of the protein are produce by using centiscape.
Figure 5. The degree and betweenness of the protein are produce by using centiscape.
Preprints 107087 g005
Table 2. Degree and betweenness obtain using centiscape.
Table 2. Degree and betweenness obtain using centiscape.
GENES DEGREE BETWEENES

ERBB2

0

0

LZTFL1

0

0

ZDHHC7

0

0

PLA2G3

0

0

BCAS3

0

0

TREM1

0

0

ABCB10

0

0

ECT2

1

0
TRPC4 0 0
OXSM 0 0

ANLN

1

0
Table 3. Chemical constituent of green tea obtain from PubChem.
Table 3. Chemical constituent of green tea obtain from PubChem.
Epigallocatechin Gallocatechol
Epicatechin gallate Gallic acid
Catechin Theaflavin
Theanine Chlorogenic acid
Theobromine Epicatechin 3 gallate
Catechol epigallocatechin
Gallocatechin linolool
Quinic acid
Table 4. Binding Affinity between ligand and protein.
Table 4. Binding Affinity between ligand and protein.



Ligand


Binding Affinity


Ligand

Binding Affinity


ABCB10_catechin


-6.6

ERBB2_catechin

-7.5


ABCB10_CATECHOL


-4.4
ERBB2_CATECHOL -5.2


ABCB10_chlorogenic_acid


-6.4

ERBB2_chlorogenic_acid

-7



ABCB10_epicatechin_3_gallate



-7.3

ERBB2_epicatechin_3_galla te


-8.8


ABCB10_epicatechin_gallate


-7.2
ERBB2_epicatechin_gallate -7.6


ABCB10_epigallocatechin


-7.2

ERBB2_epigallocatechin

-8.9


ABCB10_epigallocatechol


-6.7

ERBB2_epigallocatechol

-7.5


ABCB10_gallic_acid


-5

ERBB2_gallic_acid

-6.3


ABCB10_gallocatechin


-6.8

ERBB2_gallocatechin

-7.2


ABCB10_gallocatechol


-6.8

ERBB2_gallocatechol

-7.2


ABCB10_linalool


-5

ERBB2_linalool

-5


ABCB10_quinic_acid


-4.9
ERBB2_quinic_acid -5.9


ABCB10_theaflavin


-7.9

ERBB2_theaflavin

-9.4


ABCB10_theanine


-4.4
ERBB2_theanine -4.6


ABCB10_theobromine


-5.1

ERBB2_theobromine

-5.3

TREM1_catechin

-6.5

TREM1_linalool

-4.3

TREM1_CATECHOL

-5.2

TREM1_quinic_acid

-5.1

TREM1_chlorogenic_acid

-7.1

TREM1_theaflavin

-7.7

TREM1_epicatechin_3_gallate

-7.3

TREM1_theanine

-4.4

TREM1_epicatechin_gallate

-6.9

TREM1_theobromine

-4.6
TREM1_epigallocatechin -6.9 TREM1_gallocatechin -6.6

TREM1_epigallocatechol

-6.5

TREM1_gallocatechol

-6.6


TREM1_gallic_acid


-5.6

Discussion

Breast cancer has a high rate of metastasis and a fatality rate of over 70% when it spreads. It is well acknowledged that surgical excision is the primary treatment for most cases of breast cancer.After doing a gene set enrichment analysis, we were able to identify 158 target genes in this study. The carcinogenic process's genetic modifications affect how cells function, enabling self-sufficiency in growth signals, insensitivity to antigrowth signals, escape from apoptosis, infinite replicative potential, invasion, angiogenesis, and metastasis. These changes are consistent with the enriched biological processes—such as "cell differentiation," "cell division," "cell adhesion," and "signal transduction"—that were found using GeneCodis analysis (Table 1). The appropriate genes are then exported to the STRING database to check and analyse the protein-protein interaction along with the study of different types of nodes present. The same genes are as well transferred to the Cytoscape to visualize the interaction of targets more flexibly. With the targeted gene we came across the degree and betweenness of the genes, which helped us to imply the candidate genes for the further analysis with drugs.

Conclusion

The genes that have shown the targeted interaction are: ECT1 and ANLN.
From the above network pharmacology with various analytical tools, we came to the conclusion that, with the incidence of breast cancer on the rise and patient expectations rising in recent years, selecting an appropriate treatment to maximize preservation of function and minimize the risk of metastasis and recurrence remains challenging. In the clinic, surgical excision is frequently considered the best course of action for treating breast cancer. Non-surgical techniques like photodynamic therapy (PDT), radiation therapy, cryotherapy, and chemotherapy are commonly used to treat late-stage breast cancer. However, research on pharmaceutical therapy is still lacking, and more studies are needed to help develop novel therapeutic strategies.
Even though the efficacy of the currently available drug therapies is limited, and the discovery of new drug therapies using traditional methods is likely to take a long time, drug repositioning may speed up the process of discovering additional conditions that existing drugs could treat more effectively and potentially at a lower cost. This study aimed to investigate new drug therapies for breast cancer by means of computational methods including text mining, biological process and pathway analysis, protein-protein interaction (PPI) analysis to mine public databases, and bioinformatics tools to systematically identify interaction networks between drugs and gene targets. We were able to use data analytical techniques to look at the characteristics of possible genes in order to select a medication.
With the help of these targeted candidate genes, we can further take the analysis towards the gene-drug data interpretation and find the genes that can be used as a biomarker in correspondence with the drugs compounded for the breast cancer.

References

  1. ZJinrui, Huang. (2022). Research on the Growth of Breast Tumor. Advances in social science, education and humanities research. [CrossRef]
  2. Mr., Jayantkumar, Rathod., Pushvin, Gowda, M, R., Preethi, M., Manila, S, Koddaddi., Bindhu, R. (2023). A Review Paper on Brief Study on Breast Cancer Classification using Deep Learning. International Journal of Advanced Research in Science, Communication and Technology, 18-20. [CrossRef]
  3. Dong, Y., Tao, B., Xue, X. et al. Molecular mechanism of Epicedium treatment for depression based on network pharmacology and molecular docking technology. BMC Complement Med Ther 21, 222 (2021). [CrossRef]
  4. Chandran, U., Mehendale, N. E. E. L. A. Y., Tillu, G. I. R. I. S. H., & Patwardhan, B. H. U. S. H. A. N. (2015, June). Network pharmacology: an emerging technique for natural product drug discovery and scientific research on ayurveda. In Proc Indian Natn Sci Acad (Vol. 81, No. 3, pp. 561-8).
  5. Vijayarani, S., Ilamathi, M. J., & Nithya, M. (2015). Preprocessing techniques for text mining-an overview. International Journal of Computer Science & Communication Networks, 5(1), 7-16.
  6. Charlie, Mayor., Lyn, Robinson. (2014). Ontological realism and classification: Structures and concepts in the Gene Ontology. 65(4):686-697. [CrossRef]
  7. Doncheva, N. T., Morris, J. H., Gorodkin, J., & Jensen, L. J. (2018). Cytoscape StringApp: network analysis and visualization of proteomics data. Journal of proteome research, 18(2), 623-632. [CrossRef]
  8. Wu, G., Dawson, E., Duong, A., Haw, R., & Stein, L. (2014). ReactomeFIViz: a Cytoscape app for pathway and network-based data analysis. F1000Research, 3. [CrossRef]
  9. Yuyan, Pan., Yong, Zhang., Jiaqi, Liu. (2018). Text mining-based drug discovery in cutaneous squamous cell carcinoma. Oncology Reports, 40(6):3830-3842. [CrossRef]
  10. Noor, F., Tahir ul Qamar, M., Ashfaq, U. A., Albutti, A., Alwashmi, A. S., & Aljasir, M. A. (2022). Network pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals, 15(5), 572. [CrossRef]
  11. S Azmi, A. (2013). Adopting network pharmacology for cancer drug discovery. Current drug discovery technologies, 10(2), 95-105.
  12. Pei, C., Yang, K., Chen, Y., Dong, Y., Meng, X., & Song, N. (2024). Mechanisms of action of Qinghao in treating breast cancer and doxorubicin-induced cardiotoxicity based on network pharmacology and molecular docking. [CrossRef]
  13. Hopkins, A. L. (2008). Network pharmacology: the next paradigm in drug discovery. Nature chemical biology, 4(11), 682-690. [CrossRef]
  14. Li, Z., Han, P., You, Z. H., Li, X., Zhang, Y., Yu, H., ... & Chen, X. (2017). In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences. Scientific reports, 7(1), 11174. [CrossRef]
  15. Robert, C., Goldman. (2020). Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem.. Infectious disorders drug targets. [CrossRef]
  16. Rupali, Patil, Bhagat., Mitali, B, Ghormade. (2020). Docking of rigid macromolecules using autodok. Journal of emerging technologies and innovative research.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2024 MDPI (Basel, Switzerland) unless otherwise stated